Journal of Biological Chemistry · 2006 · 71 citations · 50 references
Life SciencesCell BiologyOncologyCell SignalingEndocytosisMolecular OncologyCancer Cell SignalingCell MigrationCellular Responses To HypoxiaHypoxia AdaptationRenal Cell CarcinomaTumor Suppressor GenesCell Migration MechanismsEndocytic RegulationHypoxia-inducible Factor ActivationHypoxia-inducible Factor RegulationHypoxia-inducible Factor SignalingHypoxia-inducible SignalingVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
The tumor suppressor VHL (von Hippel-Lindau protein) serves as a negative regulator of hypoxia-inducible factor-alpha subunits. However, accumulated evidence indicates that VHL may play additional roles in other cellular functions. We report here a novel hypoxia-inducible factor-independent function of VHL in cell motility control via regulation of fibroblast growth factor receptor 1 (FGFR1) endocytosis. In VHL null tumor cells or VHL knock-down cells, FGFR1 internalization is defective, leading to surface accumulation and abnormal activation of FGFR1. The enhanced FGFR1 activity directly correlates with increased cell migration. VHL disease mutants, in two of the mutation hot spots favoring development of renal cell carcinoma, failed to rescue the above phenotype. Interestingly, surface accumulation of the chemotactic receptor appears to be selective in VHL mutant cells, since other surface proteins such as epidermal growth factor receptor, platelet-derived growth factor receptor, IGFR1, and c-Met are not affected. We demonstrate that 1) FGFR1 endocytosis is defective in the VHL mutant and is rescued by reexpression of wild-type VHL, 2) VHL is recruited to FGFR1-containing, but not EGFR-containing, endosomal vesicles, 3) VHL exhibits a functional relationship with Rab5a and dynamin 2 in FGFR1 internalization, and 4) the endocytic function of VHL is mediated through the metastasis suppressor Nm23, a protein known to regulate dynamin-dependent endocytosis.
50
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Farida Latif, Kálmán Tory, James R. Gnarra et al. · Science · 1993 · 3K citations
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Peter Staller, Jitka Sulitkova, Joanna Lisztwan et al. · Nature · 2003 · 865 citations · Full text
Medicine, Immunology, Oncology +12
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Keiichi Kondo, Jeff Klco, Eijiro Nakamura et al. · Cancer Cell · 2002 · 769 citations · Full text